You are here

Vernakalant

FDA makes it official, once again rejecting battered Correvio’s heart drug

Endpoints

Mon, 12/30/19 - 09:55 am

complete response letter

atrial fibrillation

Deserted by Astellas and Merck, little Correvio still can't win over FDA panel concerned with its AFib drug's safety

Endpoints

Wed, 12/11/19 - 10:29 am

clinical trials

atrial fibrillation

Cardiome publishes positive data from vernakalant, propafenone comparative study

Yahoo/Fly on the Wall

Mon, 09/23/13 - 09:20 am

atrial fibrillation

Cardiome to pay $20 million, settle debt deal with Merck

Reuters

Tue, 12/11/12 - 11:05 am

Merck Returns To Cardiome All Rights To Atrial Fibrillation Drug Vernakalant

Forbes

Wed, 09/26/12 - 10:02 pm

atrial fibrillation

Cardiome Investors: Why Shares Crashed 50%

Motley Fool

Tue, 03/20/12 - 10:02 am

Cardiome provides update on Merck's development plans for Vernakalant Oral

The Fly on the Wall

Mon, 03/19/12 - 09:22 am

atrial fibrillation

Merck snags Astellas' U.S. rights to IV vernakalant

Fierce Biotech

Wed, 07/27/11 - 02:39 pm

atrial fibrillation

Cardiome shares battered by clinical trial halt

Marketwatch

Thu, 10/21/10 - 11:08 am

clinical trials

Cardiome Jumps on Drug Progress

TheStreet.com

Thu, 09/2/10 - 08:15 am

Merck says European Union agrees to review intravenous version of heart drug vernakalant

Yahoo/AP

Wed, 08/26/09 - 03:43 pm

Cardiome Pharma receives $15 million payment as part of Merck partnership

Yahoo/AP

Tue, 07/28/09 - 06:19 pm

Merck Strong in Cardiovasculars

Yahoo/Zacks.com

Sat, 07/11/09 - 08:43 am

Portola Pharmaceuticals

Schering Plough